Adedayo A Onitilo1, Jessica M Engel2, Rachel V Stankowski3, Suhail A R Doi4. 1. Department of Hematology/Oncology, Marshfield Clinic-Weston Center, Weston, Wisconsin, USA School of Population Health, University of Queensland, Brisbane, Australia onitilo.adedayo@marshfieldclinic.org. 2. Department of Hematology/Oncology, Marshfield Clinic Cancer Care, Stevens Point, Wisconsin, USA. 3. Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA. 4. School of Population Health, University of Queensland, Brisbane, Australia.
Abstract
OBJECTIVES: Evidence suggests superiority of breast conserving surgery (BCS) plus radiation over mastectomy alone for treatment of early stage breast cancer. Whether the superiority of BCS plus radiation is related to the surgical approach itself or to the addition of adjuvant radiation therapy following BCS remains unclear. MATERIALS AND METHODS: We conducted a retrospective cohort study of women with breast cancer diagnosed from 1994-2012. Data regarding patient and tumor characteristics and treatment specifics were captured electronically. Kaplan-Meier survival analyses were performed with inverse probability of treatment weighting to reduce selection bias effects in surgical assignment. RESULTS: Data from 5335 women were included, of which two-thirds had BCS and one-third had mastectomy. Surgical decision trends changed over time with more women undergoing mastectomy in recent years. Women who underwent BCS versus mastectomy differed significantly regarding age, cancer stage/grade, adjuvant radiation, chemotherapy, and endocrine treatment. Overall survival was similar for BCS and mastectomy. When BCS plus radiation was compared to mastectomy alone, 3-, 5-, and 10-year overall survival was 96.5% vs 93.4%, 92.9% vs 88.3% and 80.9% vs 67.2%, respectively. CONCLUSION: These analyses suggest that survival benefit is not related only to the surgery itself, but that the prognostic advantage of BCS plus radiation over mastectomy may also be related to the addition of adjuvant radiation therapy. This conclusion requires prospective confirmation in randomized trials.
OBJECTIVES: Evidence suggests superiority of breast conserving surgery (BCS) plus radiation over mastectomy alone for treatment of early stage breast cancer. Whether the superiority of BCS plus radiation is related to the surgical approach itself or to the addition of adjuvant radiation therapy following BCS remains unclear. MATERIALS AND METHODS: We conducted a retrospective cohort study of women with breast cancer diagnosed from 1994-2012. Data regarding patient and tumor characteristics and treatment specifics were captured electronically. Kaplan-Meier survival analyses were performed with inverse probability of treatment weighting to reduce selection bias effects in surgical assignment. RESULTS: Data from 5335 women were included, of which two-thirds had BCS and one-third had mastectomy. Surgical decision trends changed over time with more women undergoing mastectomy in recent years. Women who underwent BCS versus mastectomy differed significantly regarding age, cancer stage/grade, adjuvant radiation, chemotherapy, and endocrine treatment. Overall survival was similar for BCS and mastectomy. When BCS plus radiation was compared to mastectomy alone, 3-, 5-, and 10-year overall survival was 96.5% vs 93.4%, 92.9% vs 88.3% and 80.9% vs 67.2%, respectively. CONCLUSION: These analyses suggest that survival benefit is not related only to the surgery itself, but that the prognostic advantage of BCS plus radiation over mastectomy may also be related to the addition of adjuvant radiation therapy. This conclusion requires prospective confirmation in randomized trials.
Authors: Andrew W Dick; Melony S Sorbero; Gretchen M Ahrendt; James A Hayman; Heather T Gold; Linda Schiffhauer; Azadeh Stark; Jennifer J Griggs Journal: J Natl Cancer Inst Date: 2011-01-03 Impact factor: 13.506
Authors: Walley J Temple; Margaret L Russell; Louise L Parsons; Sylvia M Huber; Charlotte A Jones; Jane Bankes; Michael Eliasziw Journal: J Clin Oncol Date: 2006-07-20 Impact factor: 44.544
Authors: Dawn L Hershman; Donna Buono; Judith S Jacobson; Russell B McBride; Wei Yann Tsai; Kathie Ann Joseph; Alfred I Neugut Journal: Ann Surg Date: 2009-05 Impact factor: 12.969
Authors: E Shelley Hwang; Daphne Y Lichtensztajn; Scarlett Lin Gomez; Barbara Fowble; Christina A Clarke Journal: Cancer Date: 2013-01-28 Impact factor: 6.860
Authors: Gabriel De la Cruz Ku; Manish Karamchandani; Diego Chambergo-Michilot; Alexis R Narvaez-Rojas; Michael Jonczyk; Fortunato S Príncipe-Meneses; David Posawatz; Salvatore Nardello; Abhishek Chatterjee Journal: Ann Surg Oncol Date: 2022-07-25 Impact factor: 4.339
Authors: Nicolai J Toft; Trine V Axelsen; Helene L Pedersen; Marco Mele; Mark Burton; Eva Balling; Tonje Johansen; Mads Thomassen; Peer M Christiansen; Ebbe Boedtkjer Journal: Elife Date: 2021-07-05 Impact factor: 8.140
Authors: Nora H Trabulsi; Alaa A Shabkah; Reem Ujaimi; Omar Iskanderani; Mai S Kadi; Nuran Aljabri; Liane Sharbatly; Manal N AlOtaibi; Ali H Farsi; Mohammed O Nassif; Abdulaziz M Saleem; Nouf Y Akeel; Nadim H Malibary; Ali A Samkari Journal: Cureus Date: 2021-06-08
Authors: Mark Gray; Arran K Turnbull; James Meehan; Carlos Martínez-Pérez; Charlene Kay; Lisa Y Pang; David J Argyle Journal: Front Vet Sci Date: 2020-07-23